Press

March 23, 2023 – The Society for Clinical Research Sites (SCRS) today announced a Global Impact Partnership with YPrime, an eClinical systems provider offering cloud-based systems such as interactive response technology (IRT), electronic clinical outcome assessment (eCOA) and eConsent. As a Global Impact Partner (GIP), YPrime will collaborate with SCRS as well as other solution providers, sponsors, CROs and sites to develop site-focused programs and resources. Mike Hughes, Chief Product Officer at YPrime, expressed his enthusiasm for this partnership, “As a technology company, YPrime’s focus has always been on developing innovative solutions that blend into the site workflow while helping to transform systems and processes for the better.” He continued, “We’re eager for this opportunity to collaborate with other life science companies on strategies that continue to help improve site performance and sustainability.” “SCRS welcomes the YPrime team to the GIP program,” shared Sean Soth, VP of Global Business Partnerships, SCRS. “YPrime has a deep experience with technology designed with the user experience in mind. With nearly 25,000 site users across their platforms, the YPrime team continues to connect site feedback into their solution suite. SCRS is pleased to include YPrime in our technology-facing initiatives and Summits as a Global Impact Partner.” About YPrime YPrime has more than 10 years of experience designing cloud-based technology solutions to meet the needs of today’s complex challenges while innovating for tomorrow’s clinical trials. From designers and developers to managers and support techs, our seasoned team works with one goal in mind: Ensuring an optimal experience for sponsors, sites, and patients. About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager communications@myscrs.org 410.696.5080

March 16, 2023 – Today the Society for Clinical Research Sites (SCRS) announced that Velocity Clinical Research has joined the organization as a Global Impact Partner (GIP). The world’s largest fully integrated site organization, Velocity delivers high-quality data, exemplary patient care, and unprecedented efficiency for clinical trials at any scale. As part of this partnership, Velocity will align with more than 50 other Global Impact Partners comprised of sites, sponsors, CROs, and service providers dedicated to establishing meaningful collaboration between industry stakeholders and clinical research sites. Paul Evans, PhD, President and CEO of Velocity, said the company is excited to leverage this partnership to further improve clinical research, both within Velocity and industry-wide. “The SCRS community can play an integral role in the way sites shape and share best practices — through advocating on our behalf, connecting us with other sites, Sponsors, and CROs, and providing one another with mentorship and educational opportunities. With this enhanced partnership, we look forward to sharing our expertise with SCRS and other GIP members on a greater scale.” “Velocity is an integral part of the SCRS community,” commented Marcus Maleck, Director of Global Business Partnerships. “We are excited to expand this partnership further and welcome the Velocity team to the GIP program. Sites joining the GIP program provides even more opportunities for solution-focused dialogue and program development with the SCRS leadership team and our extensive GIP community.” About Velocity Clinical Research Velocity Clinical Research is the world’s leading site organization, with more than 70 owned and integrated clinical research sites and 225 investigators across the U.S. and Europe. Velocity partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, diagnostics, and combination products that could improve human health and wellbeing. Velocity is committed to delivering high-quality data, exemplary patient care, and unprecedented efficiency for clinical trials at any scale. Learn more at VelocityClinical.com. About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080

March 9, 2023 – The Society for Clinical Research Sites (SCRS) has announced the launch of a new Site Payment Initiative. The initiative will be comprised of clinical research site leaders, sponsors and CROs committed to addressing financial burdens at the site level. Some of the initial goals of the program will aim to mitigate various financial challenges of sites such as holdback payments, patient stipend taxes, and delayed payment frequencies, among other objectives. Karen McIntyre, Senior Director, Patient Innovation Centre, Parexel, commented, “Investigative sites’ financial security and sustainability is in the interest of every sponsor and CRO. For the past decade, nearly 60% of sites have reported 6 months or less operating cash. Today 76% of clinical trial agreements continue to apply a withholding payment embedded since the early 1990s when data was transported by people rather than technology. The purpose of the SCRS Payments Initiative is to create a fair state where sites are paid 100% of earned revenue, payment terms are monthly rather than quarterly, and clinical trial volunteers are not penalized through tax.” Casey Orvin, Chief Commercial Officer, CenExel added, “Running a successful site or site network is complicated, especially with the current state of site financials. Addressing these crucial financial challenges of sites, such as delayed payment frequencies and holdback payments, is key to enabling site success. I’m excited and look forward to co-leading this initiative within SCRS and the working group of sites, sponsors, and CROs to advocate for better payment practices in our industry.” “Many of these payment and financial challenges have unfortunately burdened sites for decades,” said Allyson Small, Chief Operating Officer, SCRS. “A unified voice to advocate for the financial needs of sites and patients is still very much needed, and we are confident that now is the time to enact change. By working with this group of motivated sites and industry partners, we hope to enhance sustainable practices that benefit clinical research as a whole.” SCRS has previously developed several white papers surrounding site payments which are available on the SCRS website, and will plan to release more resources as part of this program. If interested in participating in this Site Payment Initiative, please reach out to info@myscrs.org. About SCRSFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

March 6, 2023 – The Society for Clinical Research Sites (SCRS) announced today that ProofPilot, the clinical research industry’s only digital protocol automation platform, has joined the organization as a Global Impact Partner (GIP). “We are thrilled to partner with SCRS for its highly reputable GIP program, and we look forward to engaging with site staff directly to help ease the burden of research conduct through our digital protocol solution,” said Chris Venezia, Chief Executive Officer of ProofPilot. “We have received excellent feedback from research coordinators and sponsors, and we look forward to enhancing our product  through important conversations offered through the SCRS GIP model.” The SCRS GIP program provides industry sponsors, CROs, solution providers and sites the opportunity to directly engage with SCRS and its members. Becoming a GIP demonstrates ProofPilot’s commitment to developing a deeper understanding of the needs of research sites and contributing to the development of innovative solutions in the clinical research marketplace. GIPs provide input on strategic initiatives for the organization and meaningfully contribute to SCRS events, publications and committees. “ProofPilot’s team shares a deep experience in site-facing solutions” said Sean Soth, SCRS VP of Global Business Partnerships. “Reducing protocol complexity and improving site workflow are benefits our community embraces.  SCRS is pleased to include ProofPilot as a Global Impact Partner, and looks forward to ongoing collaborations across many SCRS events and programs.” About ProofPilotProofPilot supports clinical trials with the industry’s first fully automated digital protocol platform. The platform orchestrates stakeholder tasks and technology, optimizing clinical workflows, improving stakeholder experiences, and maximizing data quality. ProofPilot eliminates guesswork and reduces protocol deviations to create high-performance experiences for sites and patients. To learn more, visit https://www.proofpilot.com. Stay up-to-date on ProofPilot news at: https://www.linkedin.com/company/proofpilot      About SCRSFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

January 9, 2023 – The Society for Clinical Research Sites (SCRS) is pleased to announce Karri Venn, COO and President at Centricity Research, as the new SCRS Global Site Solutions Summit Committee Chair. Comprised of experts from research sites, solution providers, CROs and sponsors, the Global Site Solutions Summit Committee provides direction on activities for the Global Summit, held annually in the United States. Venn announced her acceptance of the role at the 2022 Global Site Solutions Summit in Hollywood, Florida. “This conference and community of sites have been instrumental in my own personal and professional growth,” said Venn. “It’s an incredible family of sites and industry that are open to collaboration and finding solutions to the barriers we face on a day-to-day basis. I am more than grateful to be giving back by taking on this role and hope to serve this community to the best of my abilities. I welcome suggestions and feedback to ensure SCRS best serves the site community as we find a path forward and embrace change.” “Karri has been an integral part of the SCRS Global Summit since 2012, as well as Summit co-chair since 2021,” said Allyson Small, SCRS Chief Operating Officer. “SCRS aims to grow and improve the Global Summit each year, and we are confident Karri’s dedication and innovation will help us achieve this goal. We look forward to exploring ways to expand our solution-focused programming for sites and industry partners with Karri’s leadership.” About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

December 19, 2022 – Today the Society for Clinical Research Sites (SCRS) released two resources for the clinical research site community as part of a new Site Invoiceables Toolkit. The Site Invoiceables Guide contains a detailed overview of common billable items that a site should consider when assessing costs associated with a clinical trial. The goal of the document is to provide clarity to the terminology of line item invoiceables that are not uncommon in budgets and should be considered if applicable. It does not indicate specifics such as when or how much to invoice. The second resource, the Invoiceables Calculation Spreadsheet, helps calculate the items described in the Site Invoiceables Guide. Both resources are designed to help guide and provide insight into common costs for conducting clinical trials. While the Site Invoiceables Guide is available to everyone, the Invoiceables Calculation Spreadsheet is exclusively for SCRS members. “Unfunded, yet essential, study activities are a longstanding problem for the sustainability of studies,” said David Vulcano, Honorary President, SCRS. “These types of invoiceables, often called ‘hidden costs’, are generally not accounted for in the study budgeting process which can be detrimental to long-term site sustainability. We hope these resources will help provide a foundation for a more productive budgeting discussion to assure a study has enough resources to be successful.” “Many sites struggle with budget negotiations and determining which items are appropriate to invoice,” commented Jimmy Bechtel, VP of Site Engagement, SCRS. “The resource that our community and the project leadership team has helped produce is something that sites of all size and experience level can benefit from. In an age of site sustainability challenges, we are confident this resource will be valuable to negotiate fair and equitable trial budgets, which will benefit all industry stakeholders.” Both resources were created by a key project team consisting of SCRS leadership and several clinical research sites. SCRS also acknowledges and appreciates the many community members that contributed to the content of this work through conversations, online community discussions and industry meetings. Access the Site Invoiceables Toolkit at myscrs-new.local/site-invoiceables-toolkit. About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

December 15, 2022 – The Society for Clinical Research Sites (SCRS) announced today that EQRx, a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions, has joined SCRS as a Global Impact Partner (GIP). The SCRS GIP Program provides unique opportunities for industry sponsors, CROs, solution providers and sites to collaborate on initiatives to address site-facing challenges. Becoming a GIP demonstrates EQRx’s commitment to develop a deeper understanding of the needs of sites and contribute to the development of site-focused solutions in the marketplace. “We are pleased to join SCRS to further enhance our clinical trial operations and collaboration with the clinical research site community,” said Christian Antoni, M.D., Ph.D., chief global development officer of EQRx. “This partnership will further our ability to conduct efficient clinical trials as we continue to work to address prevalent disease areas with new, innovative medicines.” “SCRS is excited to welcome EQRx to the Global Impact Partner community, where listening to site voices is a top priority,” said Sean Soth, SCRS VP of Global Business Partnerships. “EQRx is working on important developments in the oncology and immune-inflammatory spaces, which are key therapeutic areas for SCRS as well. We look forward to collaborating with the EQRx team as part of the GIP program to continue bridging the gap between pharmaceutical industry stakeholders and sites.” About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080

December 8, 2022 – The Society for Clinical Research Sites has announced the launch of SCRS West: Clinical Tech and Innovation Summit. This conference and expo will focus on highlighting the site voice as the industry approaches innovations and technology solutions for research. The inaugural SCRS West Summit will be held June 7-8, 2023 at The Scott Resort in Scottsdale, Arizona. SCRS West invites executives and leadership teams from sites, sponsors, CROs and industry solution providers involved in technology development and implementation. Individuals responsible for industry innovation, product design, technology adoption and management should attend. “SCRS has been planning this new Summit since 2019 when the SCRS Digital Innovation Initiative began to address gaps in DCT planning and the opportunities around improved approaches to technology use for research sites. SCRS research has shown that increasing site feedback can improve protocol design and address potential risks for technology and data challenges in studies,” said Sean Soth, SCRS VP of Global Business Partnerships. “SCRS West will flip traditional thinking about technology rollout, training and use while exploring new ideas and innovations being brought to market. The site voice is critical for clinical technology, and our community is excited to share experiences and ideas that can impact technology now and in the near future.” Registration for the 2023 SCRS West Summit is open now at scrswest.com. Learn more about exhibitor and sponsorship opportunities at scrsprograms.com. About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080

December 1, 2022 – The winner has been selected for the 2022 European Site Spark award, which recognizes outstanding and innovative work of research sites that are implementing new and exciting ways to operationalize trials. The Clinical Research Center, based in the Czech Republic and Slovakia, was chosen based on their presentation focused on its clinical trial management system (CTMS), CRC Tool. CRC Tool was developed as a central database for budget and expense tracking, visit scheduling, staff time management, and measuring key performance indicators (KPIs) for recruitment and retention. CRC Tool also serves as a quality documents database with all actual SOPs, forms and working instructions available to all relevant SMO members, including PIs. “Winning the Site Spark award that recognizes outstanding and innovative work of research sites is a great achievement for an SMO operating in two small central European countries,” said Michaela Vancova, Managing Director at Clinical Research Center. “Our CTMS system, CRC Tool, was created by software developer Jan Škaloud and is a result of several years of teamwork and professionalism. CRC Tool is a multifunctional management system that proves that if you really work hard, nothing is impossible. Receiving this award gave us the motivation to continue, strengthened our team spirit, showed that it makes sense to share our ideas, and gave us that spark that makes our work especially meaningful.” Jimmy Bechtel, SCRS VP of Site Engagement, added, “The Site Spark award acknowledges sites that have shown ingenuity, passion and inclusivity in addressing the ever-changing needs of clinical research. Congratulations to the Clinical Research Center for their outstanding achievement!” The 2022 finalists were Clinical Research Center CZ, Institut Claudius Regaud – IUCT-O and Luz Saúde – Hospital da Luz Learning Health. The three finalists presented their ideas to an audience of 250 clinical research industry stakeholders at the 2022 European Site Solutions Summit in Lisbon, Portugal. Learn more about the Site Spark award and European Site Solutions Summit at eusitesolutionssummit.com. About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org

November 28, 2022 – The Society of Clinical Research Sites (SCRS) is pleased to announce Piotr Sawicki, Head of Clinical Trials Department at Centrum Medyczne CMP, as the new SCRS European Site Solutions Summit committee chair. The European Site Solutions Summit committee provides direction for activities related to the annual European Site Solutions Summit, such as identifying thought leaders and relevant content for the Summit. “The SCRS European Summit is a unique event fully dedicated to clinical research sites and it is growing every year,” said Sawicki. “We have been building a strong community of European research sites and gained the focus of our industry partners, commencing a site-centricity era for the region. I am proud to be a member of this great community and honored to be selected as the European Summit chair. Following the great example of my predecessor Viviënne van de Walle, I will continue to strengthen the site voice in the European research community. I strongly encourage all stakeholders to join us and shape the future of the European clinical research market together for the good and health of our patients.” “Piotr has been a tremendous resource and advocate for European clinical research sites as a key contributor to the European Summit committee for several years,” added Allyson Small, SCRS Chief Operating Officer. “SCRS is thrilled to continue expanding the programming and impact of the European Summit with Piotr as the new chair. We look forward to facilitating more solution-focused discussions and strategic connections for this region.” Sawicki was announced as the new chairperson at the 2022 European Site Solutions Summit in Cascais, Portugal by Viviënne van de Walle, who most recently held the position for four years. Learn more about the European Summit at eusitesolutionssummit.com. About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

November 2, 2022 – The Society for Clinical Research Sites (SCRS) is pleased to welcome Teckro as an Oncology Spirit Partner. SCRS Oncology Spirit Partners serve on the SCRS Oncology Advisory Board with leadership roles in its Oncology Program and strategic working groups.  Through this partnership, Teckro will be actively involved in the SCRS Oncology Program and the Global Oncology Site Solutions Summit held annually in Austin, Texas. The Oncology Summit brings research sites, sponsors, CROs, and solution providers together to learn and communicate solutions for more efficient and accessible oncology research.   “As the Teckro representative to the SCRS Oncology Program, my goal is to leverage my clinical trial experience at leading companies such as GSK and Novartis so that together we find ways to simplify oncology trials for everybody working on them and improve the patient experience,” said Jennifer Weinberg, Teckro director of oncology strategy.   “With oncology research becoming increasingly more complex and demanding for sites and their patients, strategic industry alliances are working to drive solutions forward quickly. SCRS commends Teckro for their commitment to the SCRS Oncology Spirit Partnership and supporting oncology sites around the world,” said Marcus Maleck, SCRS Director of Global Business Partnerships. Learn more about the SCRS Oncology program and Global Oncology Site Solutions Summit at myscrs-new.local/about/scrs-oncology-program  About Teckro  Teckro is the digital clinical trial protocol in a simple, easy-to-use mobile app. Investigators, research staff, monitors and study teams are digitally interconnected with each other and study knowledge when and where it is needed. Loved by sites, thousands of investigators and more than 33,000 study sites around the world rely on Teckro to safely conduct clinical research. Teckro works with emerging biotech and global biopharma companies for all therapeutic areas, trial phases, and trial formats. For more information, visit teckro.com and connect with Teckro on LinkedIn.    About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.  Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080 

October 19, 2022 – Finalists have been announced for the 2022 Site Spark award, which recognizes outstanding and innovative work of research sites that are implementing new and exciting ways to operationalize trials. The inaugural competition will be held at the 2022 European Site Solutions Summit hosted November 14-15 in Lisbon, Portugal. The 2022 finalists are Clinical Research Center CZ, Institut Claudius Regaud – IUCT-O and Luz Saúde – Hospital da Luz Learning Health. Jimmy Bechtel, SCRS VP of Site Engagement said, “SCRS received many incredible submissions for the new Site Spark award, which shows that sites have gone above and beyond to adapt and thrive in the rapidly changing clinical research landscape. Congratulations to the finalists and we look forward to showcasing their work to the sites, sponsors, CROs and solution providers attending the 2022 European Site Solutions Summit!” Applications for the award were open to any clinical research site. The three finalists were chosen by an independent selection committee to present their ideas at the 2022 European Site Solutions Summit. Judging emphasis is placed on site-driven initiatives that are innovative, effective, and have that spark that makes our work especially meaningful. Learn more about the Site Spark award and European Site Solutions Summit at eusitesolutionssummit.com. About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact:Marissa HillCommunications ManagerSociety for Clinical Research Sitescommunications@myscrs.org

October 18, 2022 – Today the Society for Clinical Research Sites (SCRS) announced that Viviënne van de Walle has been awarded the 2022 Christine K. Pierre Site Impact Award. SCRS founder, Christine Pierre, was an industry leader who dedicated almost three decades of her life to advancing the work and voice of clinical research sites. In honor of her work and legacy, SCRS created the Christine K. Pierre (CKP) Site Impact Award to recognize an industry leader who has made an extraordinary contribution to furthering the voice of the clinical research site community. Nominations were made by the clinical research site community and open to any individuals employed by an SCRS member site. Viviënne van de Walle was selected as the recipient of this year’s award by SCRS leadership. Van de Walle studied medicine at the University of Maastricht and the University of Oxford. She has been a full-time principal investigator at several independent clinical research sites and in 2006 co-founded the independent research site PT&R. She regularly consults and educates CROs, pharmaceutical sponsors, and nutritional companies in executive and advisory board functions at trade organizations such as ACRP, SCRS, TransCelerate, CISCRP and NVFG. PT&R was also the recipient of the SCRS European Site Patient Recruitment Innovation Award (SPRIA) in 2019. Van de Walle accepted the Christine K. Pierre Site Impact Award at the 2022 Global Site Solutions Summit with more than 1,200 clinical research industry stakeholders in attendance. “Christine Pierre showed that sites are more alike than they are different. Despite our various settings and geographical locations, sites want to focus on their patients, but are facing the same challenges when conducting clinical trials – all of which have a potential impact on the sustainability of sites,” said van de Walle. “In Christine’s spirit, with perseverance and creative solution solving, it is my mission to have the various industry stakeholders understand each other, hence decreasing site burden and increasing sustainability. After all, we all have the same goal: the best for our patients and good data quality.” Allyson Small, SCRS Chief Operating Officer added, “Viviënne has been an incredible advocate for SCRS since its inception. As an SCRS Leadership Council Member and European Site Solutions Summit chair, she is a remarkable leader and voice for sites around the world. Congratulations to Viviënne for earning this prestigious award. The SCRS community thanks you for your dedication to ensuring site success and sustainability.” Learn more about the Global Site Solutions Summit and Christine K. Pierre Site Impact Award at sitesolutionssummit.com. About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080

October 17, 2022 – The Society for Clinical Research Sites (SCRS) is pleased to announce the 2022 recipients of the prestigious SCRS Eagle Award: Merck as the sponsor recipient and the PPD clinical research business of Thermo Fisher Scientific as the clinical research organization (CRO) recipient. The Eagle Award, sponsored in 2022 by Advarra, has been awarded annually since 2009 to recognize a sponsor and CRO most dedicated to outstanding leadership, professionalism, integrity, operational excellence and a commitment to advancing the clinical research profession through strong site partnerships. The SCRS community celebrated the work and progress of these organizations and the other finalists at the 2022 Global Site Solutions Summit, with more than 1,200 clinical research stakeholders in attendance. Eagle Award nominees, finalists and recipients are selected by clinical research sites around the world. Andy Lee, Senior Vice President and Head, Global Clinical Trial Operations at Merck commented, “Receiving the Eagle Award during these challenging times truly recognizes our strong collaboration with our clinical research site colleagues. We’re proud of the dedication, commitment and enduring spirit of our people and site partners to our noble work to bring medicines to patients with unmet medical needs.” “We are honored to be named an Eagle Award winner for the second consecutive year,” said David M. Johnston, Ph.D., Senior Vice President and President, Clinical Research, Thermo Fisher Scientific. “This prestigious award reflects our focus on supporting and connecting with our site partners, which in turn helps enable us to best serve our customers in pursuit of their clinical research initiatives. Our close relationships with research sites contribute to our ability to help deliver on the ambition we all share – helping deliver life-changing therapies to patients around the globe.” Sean Soth, Vice President of Global Business Partnerships at SCRS added, “After nearly 4,000 votes by clinical research sites globally, SCRS is pleased to present the Eagle Award to both Merck and PPD. We are seeing exciting progress from many leading sponsor and CRO organizations in our community, many of whom were finalists as well. While change takes time, building reciprocal partnerships and delivering what sites need to improve study outcomes is what the spirit of the Eagle Award is all about. Congratulations to Merck and PPD!” “Having supported sites, sponsors, and CROs for more than 20 years, Advarra is thrilled to celebrate successful site-centric collaborators and innovators,” said Laura Hilty, Vice President of Strategy at Advarra. “A common goal throughout the Site Solutions Summit has been addressing the burden of disparate technology systems on research sites. We believe integrating existing site and sponsor technology is the solution. We’ve already collaborated with many Eagle Award finalists and the sites that cast their votes, and it’s clear we’re headed toward a more seamless and connected ecosystem. On behalf of our team at Advarra, thank you and congratulations to the Eagle Award recipients and all those dedicated to improving operations for sites.” Learn more about the SCRS Global Site Solutions Summit and Eagle Award at sitesolutionssummit.com About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080

October 13, 2022 – The Society for Clinical Research Sites (SCRS) has announced that the University of California – Davis and Javara are the respective recipients of the Site Tank Award and Site Patient Recruitment Innovation Achievement Award (SPRIA). Site Tank, sponsored by Pfizer, recognizes a research site that has developed an innovative technology concept designed to enhance, empower and improve clinical research operations. For the Site Tank competition, the University of California – Davis Clinical and Translational Science Center presented its pilot training program for clinical research coordinators (CRCs). The program was created to address the persistent shortage of staff to support clinical trials, to increase diversity of the clinical research workforce and to provide a re-training STEM opportunity to under-resourced communities. This unique program combines classroom learning with workplace exposure to clinical research to train the next generation of CRCs. “Addressing recruitment and retention of clinical research coordinators is imperative for continuing and expanding clinical research,” said Kate Marusina, Ph.D., MBA, Director, Clinical Trials Office, UC Davis Clinical and Translational Science Center. “Our training program creates a previously untapped workforce pipeline. The unique feature of our program is its pre-competitive positioning and a strong emphasis on community engagement. In addition, by providing stipends to the trainees we contribute to the success of those individuals for whom a career in healthcare would have been unimaginable. We are changing lives one person at a time. Replication of this training blueprint across the country would be beneficial to our entire society.” Sponsored by StudyKIK, SPRIA recognizes a research site that has developed and implemented an innovative patient recruitment program. Javara presented their recruitment plan for the Infectious Disease Vaccine – RSV study, at SouthCoast Health in Savannah, Georgia. Their recruitment efforts prioritized community engagement and engaged Greater Gift, a non-profit organization with the mission to increase awareness of clinical research, especially among underrepresented communities. Javara Chief Operating Officer Mike Clay commented, “The opportunity to be a part of SCRS and the annual Site Solutions Summit is alone a great honor. We are immensely grateful to the SCRS organization for providing this space to recognize and celebrate innovation across the industry, and we are truly humbled to be the recipient of the 2022 Site Patient Recruitment Innovation Award. Our pioneering efforts focusing on community engagement, human interaction, and personalized technologies to elevate our patient enrollment strategy and improve the patient experience have proven to be impactful. However, it is our hope that through these efforts we may continue to bring clinical trials to potential participants through their most trusted source – their community – increasing access and improving lives through unity and trust.”  “Sites are more committed than ever to developing forward-thinking solutions that are truly site and patient-centric,” said Jimmy Bechtel, SCRS VP of Site Engagement. “SCRS congratulates this year’s winners – UC Davis for Site Tank and Javara for SPRIA – for their innovative efforts to enhance patient recruitment initiatives and business operations for their organizations. We look forward to featuring their strategies with our community as the industry continues to focus on efficient processes to better recruit and engage trial participants.” Three finalists for each award were chosen by an independent selection committee. After finalists presented their initiatives at the Global Site Solutions Summit, the winner was chosen by a panel of judges and announced at the Eagle Award Gala to more than 1,200 industry attendees.  For more information about Site Tank, SPRIA, and the SCRS Global Site Solutions Summit, visit sitesolutionssummit.com. About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org